Debio 1347

DRUG2 trials

Sponsors

Memorial Sloan Kettering Cancer Center, Debiopharm International SA

Conditions

Breast CancerSolid Tumor

Phase 1

A Study of Debio 1347 Plus Fulvestrant in Patients With Metastatic Breast Cancer

CompletedNCT03344536

Memorial Sloan Kettering Cancer CenterBreast Cancer

Start: 2017-11-10End: 2021-08-12Updated: 2022-11-25

Phase 2

Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)

TerminatedNCT03834220

Debiopharm International SASolid Tumor

Start: 2019-03-22End: 2022-01-04Updated: 2024-02-07

Related Papers

FUZE clinical trial: a phase 2 study of Debio 1347 in FGFR fusion-positive advanced solid tumors irrespectively of tumor histology.

Journal of Clinical Oncology2019-05-2025 citations